CEND-1
CEND1-001
Phase 1 small_molecule completed
Quick answer
CEND-1 for Pancreatic Cancer is a Phase 1 program (small_molecule) at LISATA THERAPEUTICS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- LISATA THERAPEUTICS, INC.
- Indication
- Pancreatic Cancer
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed